366 related articles for article (PubMed ID: 33818618)
1. Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes.
Kharbanda EO; Vazquez-Benitez G; DeSilva MB; Naleway AL; Klein NP; Hechter RC; Glanz JM; Donahue JG; Jackson LA; Sheth SS; Greenberg V; Panagiotakopoulos L; Mba-Jonas A; Lipkind HS
JAMA Netw Open; 2021 Apr; 4(4):e214340. PubMed ID: 33818618
[TBL] [Abstract][Full Text] [Related]
2. Risk of Spontaneous Abortion After Inadvertent Human Papillomavirus Vaccination in Pregnancy.
Kharbanda EO; Vazquez-Benitez G; Lipkind HS; Sheth SS; Zhu J; Naleway AL; Klein NP; Hechter R; Daley MF; Donahue JG; Jackson ML; Kawai AT; Sukumaran L; Nordin JD
Obstet Gynecol; 2018 Jul; 132(1):35-44. PubMed ID: 29889760
[TBL] [Abstract][Full Text] [Related]
3. Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy.
Lipkind HS; Vazquez-Benitez G; Nordin JD; Romitti PA; Naleway AL; Klein NP; Hechter RC; Jackson ML; Hambidge SJ; Lee GM; Sukumaran L; Kharbanda EO
Obstet Gynecol; 2017 Sep; 130(3):599-608. PubMed ID: 28796684
[TBL] [Abstract][Full Text] [Related]
4. Maternal and infant outcomes following exposure to quadrivalent human papillomavirus vaccine during pregnancy.
Bukowinski AT; Hall C; Chang RN; Gumbs GR; Marie S Conlin A
Vaccine; 2020 Aug; 38(37):5933-5939. PubMed ID: 32712082
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes.
Kharbanda EO; Vazquez-Benitez G; Lipkind HS; Klein NP; Cheetham TC; Naleway A; Omer SB; Hambidge SJ; Lee GM; Jackson ML; McCarthy NL; DeStefano F; Nordin JD
JAMA; 2014 Nov; 312(18):1897-904. PubMed ID: 25387187
[TBL] [Abstract][Full Text] [Related]
6. Peri-conceptional or pregnancy exposure of HPV vaccination and the risk of spontaneous abortion: a systematic review and meta-analysis.
Tan J; Xiong YQ; He Q; Liu YM; Wang W; Chen M; Zou K; Liu XH; Sun X
BMC Pregnancy Childbirth; 2019 Aug; 19(1):302. PubMed ID: 31426762
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy Outcomes After Human Papillomavirus Vaccination in Periconceptional Period or During Pregnancy: A Systematic Review and Meta-analysis.
Wang A; Liu C; Wang Y; Yin A; Wu J; Zhang C; Luo M; Du L; Xiong Y; Zhao X; Huang Y
Hum Vaccin Immunother; 2020 Mar; 16(3):581-589. PubMed ID: 31486334
[No Abstract] [Full Text] [Related]
8. Quadrivalent HPV Vaccination and the Risk of Adverse Pregnancy Outcomes.
Scheller NM; Pasternak B; Mølgaard-Nielsen D; Svanström H; Hviid A
N Engl J Med; 2017 Mar; 376(13):1223-1233. PubMed ID: 28355499
[TBL] [Abstract][Full Text] [Related]
9. Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study.
Cody P; Tobe K; Abe M; Elbasha EH
BMC Infect Dis; 2021 Jan; 21(1):11. PubMed ID: 33407188
[TBL] [Abstract][Full Text] [Related]
10. Adverse pregnancy outcomes and infant mortality after quadrivalent HPV vaccination during pregnancy.
Faber MT; Duun-Henriksen AK; Dehlendorff C; Tatla MK; Munk C; Kjaer SK
Vaccine; 2019 Jan; 37(2):265-271. PubMed ID: 30503078
[TBL] [Abstract][Full Text] [Related]
11. Association Between Fexofenadine Use During Pregnancy and Fetal Outcomes.
Andersson NW; Torp-Pedersen C; Andersen JT
JAMA Pediatr; 2020 Aug; 174(8):e201316. PubMed ID: 32478810
[TBL] [Abstract][Full Text] [Related]
12. Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth - Eight Integrated Health Care Organizations, United States, December 15, 2020-July 22, 2021.
Lipkind HS; Vazquez-Benitez G; DeSilva M; Vesco KK; Ackerman-Banks C; Zhu J; Boyce TG; Daley MF; Fuller CC; Getahun D; Irving SA; Jackson LA; Williams JTB; Zerbo O; McNeil MM; Olson CK; Weintraub E; Kharbanda EO
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(1):26-30. PubMed ID: 34990445
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women.
Ruiz-Sternberg ÁM; Moreira ED; Restrepo JA; Lazcano-Ponce E; Cabello R; Silva A; Andrade R; Revollo F; Uscanga S; Victoria A; Guevara AM; Luna J; Plata M; Dominguez CN; Fedrizzi E; Suarez E; Reina JC; Ellison MC; Moeller E; Ritter M; Shields C; Cashat M; Perez G; Luxembourg A
Papillomavirus Res; 2018 Jun; 5():63-74. PubMed ID: 29269325
[TBL] [Abstract][Full Text] [Related]
14. Safety of inactivated monovalent pandemic (H1N1) 2009 vaccination during pregnancy: a population-based study in Taiwan.
Huang WT; Tang FW; Yang SE; Chih YC; Chuang JH
Vaccine; 2014 Nov; 32(48):6463-8. PubMed ID: 25285884
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort.
Dormuth CR; Winquist B; Fisher A; Wu F; Reynier P; Suissa S; Dahl M; Ma Z; Lu X; Zhang J; Raymond CB; Filion KB; Platt RW; Moriello C; Paterson JM;
JAMA Netw Open; 2021 Apr; 4(4):e215329. PubMed ID: 33890993
[TBL] [Abstract][Full Text] [Related]
16. Association Between Fetal Safety Outcomes and Exposure to Local Podophyllotoxin During Pregnancy.
Andersson NW; Andersen JT
JAMA Dermatol; 2020 Mar; 156(3):303-311. PubMed ID: 31913405
[TBL] [Abstract][Full Text] [Related]
17. The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model.
Chesson HW; Markowitz LE; Hariri S; Ekwueme DU; Saraiya M
Hum Vaccin Immunother; 2016 Jun; 12(6):1363-72. PubMed ID: 26890978
[TBL] [Abstract][Full Text] [Related]
18. Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study.
Amend KL; Turnbull B; Zhou L; Marks MA; Velicer C; Saddier P; Seeger JD
Hum Vaccin Immunother; 2022 Nov; 18(5):2073750. PubMed ID: 35714277
[TBL] [Abstract][Full Text] [Related]
19. Abacavir and lamivudine exposures during pregnancy and non-defect adverse pregnancy outcomes: data from the antiretroviral pregnancy registry.
Vannappagari V; Koram N; Albano J; Tilson H; Gee C
J Acquir Immune Defic Syndr; 2015 Mar; 68(3):359-64. PubMed ID: 25469525
[TBL] [Abstract][Full Text] [Related]
20. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants.
Chambers CD; Johnson D; Xu R; Luo Y; Louik C; Mitchell AA; Schatz M; Jones KL;
Vaccine; 2013 Oct; 31(44):5026-32. PubMed ID: 24016809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
